HTBC

The HTBC, the precursor to the HTSKC was a Stanford University School of Medicine core facility and was created in 2003 by the Department of Chemical and Systems Biology (formerly Molecular Pharmacology). In 2022, the HTBC became the Sarafan ChEM-H HTSKC with funding from the Innovative Medicines Accelerator (IMA). The HTSKC is a shared resource (Bioscience Screening Facility) for the Stanford Cancer Institute... **The HTBC has transitioned to the High-Throughput Screening Knowledge Center (HTS KC) Please feel free to contact Bruce Koch (bkoch@stanford.edu) or David Solow-Cordero (desolow@stanford.edu) if you have any questions. Our services, compound screening, and equipment are all available as in the past... A leader in the biomedical revolution, Stanford Medicine has a long tradition of leadership in pioneering research, creative teaching protocols and effective clinical therapies.

Primary location: Stanford United States